Tag: partial AUC
Partial AUC in Bioequivalence: How Advanced Metrics Ensure Drug Safety and Efficacy
Partial AUC is a precise pharmacokinetic tool used to assess bioequivalence in complex drug formulations. Unlike total AUC, it focuses on specific time windows critical for drug effectiveness and safety-especially for extended-release and abuse-deterrent products. Regulators like the FDA now require it for over 127 drug products.
read morerecent posts
Statins and certain antifungals can cause dangerous drug interactions that raise the risk of muscle damage. Learn which combinations are risky, safer alternatives, and what to do if you're taking both.
Published ON: 10 JanPatent expiry means cheaper drugs-but only if you're prepared. Learn how patients and healthcare systems can save money and avoid disruptions when brand-name drugs go generic.
Published ON: 12 JanFeNO testing measures airway inflammation in asthma by detecting nitric oxide in exhaled breath. It helps doctors confirm diagnosis, adjust treatment, and reduce flare-ups with objective, non-invasive data.
Published ON: 14 JanOpioids in older adults increase fall risk, trigger delirium, and can be deadly at standard doses. Learn why lower doses, careful monitoring, and non-drug options are critical for safe pain management in seniors.
Published ON: 4 JanLearn how absolute and relative risk numbers in drug ads can mislead you. See why 50% risk reduction might mean just a 1% real change - and how to ask the right questions to make smarter health choices.
Published ON: 5 Jan